Trial backs stenting over surgery for gastric obstruction
This article was originally published in Clinica
Executive Summary
A study has shown that endoscopic duodenal stenting is associated with lower costs and shorter hospital stays than the surgical alternative, gastrojejunostomy (GJ).
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.